Prevalence of hepatopancreatic injury and clinical outcomes in patients with COVID-19 in USA

BACKGROUND: (1) To determine the prevalence of hepatopancreatic injury in coronavirus disease 2019 (COVID-19) patients. (2) To correlate hepatopancreatic injury in COVID-19 with mortality, disease severity, and length of stay in this cohort. RESULTS: Forty-five thousand three hundred sixty patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Rastogi, Vaibhav, Banwait, Ranjit, Singh, Devina, Toklu, Hale, Finer, Lexie, Parajuli, Dipendra, Ganti, Latha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572059/
https://www.ncbi.nlm.nih.gov/pubmed/34742236
http://dx.doi.org/10.1186/s12245-021-00393-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572059/
https://www.ncbi.nlm.nih.gov/pubmed/34742236
http://dx.doi.org/10.1186/s12245-021-00393-2

Ejemplares similares